APA (7th ed.) Citation

van den Heuvel, M., Smith, C., Schuurbiers, M., Hartemink, K., Rintoul, R., Monkhorst, K., . . . Rosenfeld, N. (2024). 1226P Predictive value of circulating tumor DNA (ctDNA) before and shortly after curative treatment in early stage non-small cell lung cancer (NSCLC), and exploration of (pre-)analytical factors. Annals of Oncology, 35, S787. https://doi.org/10.1016/j.annonc.2024.08.1285

Chicago Style (17th ed.) Citation

van den Heuvel, M., C.G Smith, M. Schuurbiers, K. Hartemink, R. Rintoul, K. Monkhorst, D. Van Den Broek, and N. Rosenfeld. "1226P Predictive Value of Circulating Tumor DNA (ctDNA) Before and Shortly After Curative Treatment in Early Stage Non-small Cell Lung Cancer (NSCLC), and Exploration of (pre-)analytical Factors." Annals of Oncology 35 (2024): S787. https://doi.org/10.1016/j.annonc.2024.08.1285.

MLA (9th ed.) Citation

van den Heuvel, M., et al. "1226P Predictive Value of Circulating Tumor DNA (ctDNA) Before and Shortly After Curative Treatment in Early Stage Non-small Cell Lung Cancer (NSCLC), and Exploration of (pre-)analytical Factors." Annals of Oncology, vol. 35, 2024, p. S787, https://doi.org/10.1016/j.annonc.2024.08.1285.